Early Findings Suggest Clinical and Lab-Based Approach Critical to Tracking Head and Neck Cancer Recurrence

Paul Swiecicki, MD has found quicker detection of HPV-positive head and neck cancer recurrence could lie in new monitoring guidelines and a more sensitive blood test.